Smith & Nephew Snats ( (SNN) ) has released its Q4 earnings. Here is a breakdown of the information Smith & Nephew Snats presented to its investors.
Smith & Nephew, a global medical technology company, specializes in the repair, regeneration, and replacement of soft and hard tissue, operating in the orthopaedics, sports medicine, and advanced wound management sectors. The company reported a strong financial performance for the fourth quarter and full year 2024, driven by its transformative 12-Point Plan, which has led to higher revenue growth, margin expansion, and improved cash flow. Key financial highlights include a 5.3% underlying revenue growth, a 54.6% increase in operating profit, and a significant rise in free cash flow by 327.1%. The company’s strategic focus on innovation and operational improvements has resulted in the launch of nearly 50 new products over the past three years, contributing significantly to its revenue growth. Looking ahead, Smith & Nephew anticipates continued revenue growth and further margin expansion in 2025, supported by ongoing operational efficiencies and a robust product pipeline.